RevitalVision Demonstrates Efficacy, Safety in Infantile Nystagmus - Takeaways - MDSpire

RevitalVision Demonstrates Efficacy, Safety in Infantile Nystagmus

Positive clinical data shows improvement in visual function in patients with infantile nystagmus

  • By

  • Conexiant News Staff

  • January 13, 2026

  • 1 min

Share

  • 1

    RevitalVision published positive clinical data for its treatment of infantile nystagmus in the British Journal of Ophthalmology.

  • 2

    The study presents the first randomized controlled evidence supporting RevitalVision's efficacy in improving visual function.

  • 3

    RevitalVision is an FDA-cleared neuroplasticity-based visual training program designed for patients with infantile nystagmus.

  • 4

    Infantile nystagmus is a congenital eye movement disorder characterized by involuntary, rhythmic oscillations of the eyes.

  • 5

    The findings indicate a significant advancement in treatment options for individuals affected by this condition.

Original Source(s)

RevitalVision Demonstrates Efficacy, Safety in Infantile Nystagmus

  • by Conexiant News Staff

  • January 13, 2026

Related Content

What are you looking at? Modality contribution in multimodal medical deep learning

AAO Opens Call for Course Proposals for Academy 2026 Anaheim

The American Academy of Optometry (AAO) has opened its call for course proposals for the educational program at Academy 2026 Anaheim, inviting optometrists and educators to submit lectures, workshops, and interactive sessions for consideration.

Multimodal human–computer interaction in interventional radiology and surgery: a systematic literature review